Phase 2 Trial Shows Cannabis Oil Does Not Improve Parkinson's Symptoms

A Phase 2 clinical trial published in Movement Disorders on August 7 found that cannabis oil did not provide meaningful improvements for pain and non-motor symptoms in Parkinson's disease patients. The study tempers growing expectations about cannabis as a therapeutic option for this neurodegenerative condition. While some patients report subjective benefits, this rigorous clinical evidence suggests cannabis oil may not be an effective treatment for Parkinson's-related pain and non-motor complications. The findings highlight the importance of evidence-based research in evaluating cannabis therapeutics before widespread medical use.